Discovery and in Vivo Evaluation of Dual PI3Kβ/δ Inhibitors

被引:42
作者
de Turiso, Felix Gonzalez-Lopez [1 ]
Shin, Youngsook [1 ]
Brown, Matthew [1 ]
Cardozo, Mario [1 ]
Chen, Yi [1 ]
Fong, David [3 ]
Hao, Xiaolin [1 ]
He, Xiao [1 ]
Henne, Kirk [2 ]
Hu, Yi-Ling [3 ]
Johnson, Michael G. [1 ]
Kohn, Todd [1 ]
Lohman, Julia [1 ]
McBride, Helen J. [3 ]
McGee, Lawrence R. [1 ]
Medina, Julio C. [1 ]
Metz, Daniela [3 ]
Miner, Kent [3 ]
Mohn, Deanna [3 ]
Pattaropong, Vatee [1 ]
Seganish, Jennifer [1 ]
Simard, Jillian L. [1 ]
Wannberg, Sharon [3 ]
Whittington, Douglas A. [4 ]
Yu, Gang [3 ]
Cushing, Timothy D. [1 ]
机构
[1] Amgen Inc, Dept Therapeut Discovery, San Francisco, CA 94080 USA
[2] Amgen Inc, Dept Pharmacokinet & Drug Metab, San Francisco, CA 94080 USA
[3] Amgen Inc, Dept Inflammat Res, Thousand Oaks, CA 91320 USA
[4] Amgen Inc, Dept Therapeut Discovery, Cambridge, MA 02142 USA
关键词
PHOSPHOINOSITIDE; 3-KINASE; RHEUMATOID-ARTHRITIS; PI3K/AKT PATHWAY; DRUG DISCOVERY; ACTIVATION; CANCER; INFLAMMATION; METABOLISM; P110-DELTA; PI3K-DELTA;
D O I
10.1021/jm300679u
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Structure-based rational design led to the synthesis of a novel series of potent PI3K inhibitors. The optimized pyrrolopyridine analogue 63 was a potent and selective PI3K beta/delta dual inhibitor that displayed suitable physicochemical properties and pharmacokinetic profile for animal studies. Analogue 63 was found to be efficacious in animal models of inflammation including a keyhole limpet hemocyanin (KLH) study and a collagen-induced arthritis (CIA) disease model of rheumatoid arthritis. These studies highlight the potential therapeutic value of inhibiting both the PI3K beta and delta isoforms in the treatment of a number of inflammatory diseases.
引用
收藏
页码:7667 / 7685
页数:19
相关论文
共 31 条
[1]   Enantiodivergent preparation of optically active oxindoles having a stereogenic quaternary carbon center at the C3 position via the lipase-catalyzed desymmetrization protocol: Effective use of 2-furoates for either enzymatic esterification or hydrolysis [J].
Akai, S ;
Tsujino, T ;
Akiyama, E ;
Tanimoto, K ;
Naka, T ;
Kita, Y .
JOURNAL OF ORGANIC CHEMISTRY, 2004, 69 (07) :2478-2486
[2]   Small Molecule Inhibitors of Phosphoinositide 3-Kinase (PI3K) δ and γ [J].
Ameriks, Michael K. ;
Venable, Jennifer D. .
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2009, 9 (08) :738-753
[3]  
Berndt A, 2010, NAT CHEM BIOL, V6, P117, DOI [10.1038/nchembio.293, 10.1038/NCHEMBIO.293]
[4]   Roles of Gβγ in membrane recruitment and activation of p110γ/p101 phosphoinositide 3-kinase γ [J].
Brock, C ;
Schaefer, M ;
Reusch, HP ;
Czupalla, C ;
Michalke, M ;
Spicher, K ;
Schultz, G ;
Nürnberg, B .
JOURNAL OF CELL BIOLOGY, 2003, 160 (01) :89-99
[5]  
Brown M., Heterocyclic compounds and their uses, Patent No. [W02010/151737 A2, 2010151737]
[6]   Discovery and Optimization of New Benzimidazole- and Benzoxazole-Pyrimidone Selective PI3Kβ Inhibitors for the Treatment of Phosphatase and TENsin homologue (PTEN)-Deficient Cancers [J].
Certal, Victor ;
Halley, Frank ;
Virone-Oddos, Angela ;
Delorme, Cecile ;
Karlsson, Andreas ;
Rak, Alexey ;
Thompson, Fabienne ;
Filoche-Romme, Bruno ;
El-Ahmad, Youssef ;
Carry, Jean-Christophe ;
Abecassis, Pierre-Yves ;
Lejeune, Pascale ;
Vincent, Loic ;
Bonnevaux, Helene ;
Nicolas, Jean-Paul ;
Bertrand, Thomas ;
Marquette, Jean-Pierre ;
Michot, Nadine ;
Benard, Tsiala ;
Below, Peter ;
Vade, Isabelle ;
Chatreaux, Fabienne ;
Lebourg, Giles ;
Pilorge, Fabienne ;
Angouillant-Boniface, Odile ;
Louboutin, Audrey ;
Lengauer, Christoph ;
Schio, Laurent .
JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (10) :4788-4805
[7]  
Chen G., Alkynyl alcohols as kinase inhibitors, Patent No. [W02009/158011A1, 2009158011]
[8]  
Chen Y., Heterocyclic compounds and their use as inhibitors of PI3K activity, Patent No. [WO2008/118468A1, 2008118468]
[9]   The PI3K inhibitor arsenal: choose your weapon! [J].
Crabbe, Tom ;
Welham, Melanie J. ;
Ward, Stephen G. .
TRENDS IN BIOCHEMICAL SCIENCES, 2007, 32 (10) :450-456
[10]   Discovery and Optimization of a Series of Benzothiazole Phosphoinositide 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Dual Inhibitors [J].
D'Angelo, Noel D. ;
Kim, Tae-Seong ;
Andrews, Kristin ;
Booker, Shon K. ;
Caenepeel, Sean ;
Chen, Kui ;
D'Amico, Derin ;
Freeman, Dan ;
Jiang, Jian ;
Liu, Longbin ;
McCarter, John D. ;
Miguel, Tisha San ;
Mullady, Erin L. ;
Schrag, Michael ;
Subramanian, Raju ;
Tang, Jin ;
Wahl, Robert C. ;
Wang, Ling ;
Whittington, Douglas A. ;
Wu, Tian ;
Xi, Ning ;
Xu, Yang ;
Yakowec, Peter ;
Yang, Kevin ;
Zalameda, Leeanne P. ;
Zhang, Nancy ;
Hughes, Paul ;
Norman, Mark H. .
JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (06) :1789-1811